This is a non-core endpoint: only basic statistics are computed.

See these related core endpoints for full statistics:

L12_HAIRLOSSSCAR

Pseudopelade

Endpoint Browser

L12_PSEUDOPELADE

No definition available.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — L66.0 Hospital discharge: ICD-9 — 7040G Cause of death: ICD-10 — L66.0 Cause of death: ICD-9 — 7040G 2 out of 7 registries used, show all original rules.	20
4. Check minimum number of events None	20
5. Include endpoints None	20
6. Filter based on genotype QC (FinnGen only)	20

Control definitions (FinnGen only)

Control exclude: L12_DISORDSKINAPPENDIX

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: L66
Name in latin: Pseudopelade Brocq

NAME	L12_PSEUDOPELADE
CONTROL_EXCLUDE	L12_DISORDSKINAPPENDIX
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	L660
HD_ICD_9	7040G
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	L660
COD_ICD_9	7040G
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Pseudopelade based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Not enough data for upset plot.

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	101	68	33
Only index persons	96	65	31
Unadjusted period prevalence (%)
Whole population	0.00	0.00	0.00
Only index persons	0.00	0.00	0.00
Median age at first event (years)
Whole population	-	45.49	29.21
Only index persons	39.61	44.57	29.21

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	20	16	-
Unadjusted period prevalence (%)	0.00	0.01	-
Median age at first event (years)	48.47	46.27	-

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

No data available

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3022145) Colonoscopy Study observation

4.74

1.83

1.0

1.7

—

(3000494) Fungus identified in Specimen by Culture

4.04

1.82

1.3

1.5

—

(40768804) Tissue Pathology biopsy report

2.90

1.55

2.1

1.9

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.82

1.16

1.2

1.7

—

(3023368) Bacteria identified in Blood by Culture

2.36

1.07

4.4

5.4

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

2.62

1.02

2.2

1.8

—

(3042936) Bacteria identified in Isolate by Culture

2.42

0.97

2.5

1.6

—

(42870588) Differential panel, method unspecified - Blood

2.00

0.70

7.3

5.3

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

0.00

0.63

0.0

3.1

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

161

0.57

0.59

24.4

14.0

80.5

81.6

ml/min/173m2

0.06

136

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1.73

0.50

2.8

3.2

21.9

28.0

u/l

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

1.68

0.45

2.2

1.3

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

1.47

0.38

1.2

1.3

—

1.1

—

(3021589) Normoblasts [#/volume] in Blood

0.65

0.33

17.4

9.4

0.0

e9/l

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

1.49

0.32

3.5

4.5

7.3

6.7

mmol/l

0.28

(3021960) Folate [Moles/volume] in Serum or Plasma

1.37

0.25

1.4

1.6

12.6

23.6

nmol/l

—

(3013512) EKG study

1.29

0.24

13.4

3.6

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1.36

0.23

1.7

1.6

1.1

mmol/l

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

0.00

0.22

0.0

1.4

—

(3022621) pH of Urine by Test strip

0.00

0.22

0.0

1.5

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

0.00

0.22

0.0

1.8

—

(4010399)

0.00

0.22

0.0

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

105

1.36

0.19

4.0

2.7

—

(3044889) 12 lead EKG panel

115

0.74

0.17

2.6

3.3

—

(40758558) Short blood count panel - Blood

1.18

0.11

8.0

9.5

—

(1761868) Lipid panel - Serum or Plasma

1.12

0.10

3.8

3.1

—

(3003694) ABO and Rh group [Type] in Blood

1.16

0.10

1.2

1.5

—

(3037467) Urinalysis macro (dipstick) panel - Urine

123

1.16

0.09

4.9

3.5

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

0.85

0.09

4.4

4.3

—

(40768793) Breast Pathology biopsy report

0.00

0.0

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

0.00

0.0

1.6

—

(40761535) Cells panel - Urine sediment

0.00

0.0

4.7

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

0.00

0.0

1.3

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3016879) Cocaine [Presence] in Urine

0.00

0.0

1.0

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.8

—

(3027944) Amphetamines [Presence] in Urine

0.00

0.0

1.0

—

(3028300) Cannabinoids [Presence] in Urine

0.00

0.0

1.0

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

0.00

0.0

1.5

—

28.4

—

(3009542) Hematocrit [Volume Fraction] of Blood

150

1.00

0.00

25.9

14.1

41.2

40.5

—

112

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.0

1.8

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

0.0

3.8

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.5

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

0.00

0.0

2.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.0

1.8

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.3

—

(3015736) pH of Urine

1.09

0.00

2.6

2.5

—

(3005322) IgE [Units/volume] in Serum or Plasma

0.00

0.0

1.0

—

189.7

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.0

1.4

—

17.4

—

(3027008) Opiates [Presence] in Urine

0.00

0.0

1.0

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

0.00

0.0

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.00

0.0

1.8

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.00

0.0

1.8

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.0

1.4

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

0.00

0.0

1.0

—

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

0.00

0.0

1.4

—

(3045414) Leukocytes [Presence] in Urine

0.00

0.0

1.6

—

(4034850)

0.00

0.0

7.6

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

0.00

0.0

2.0

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.0

1.8

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.00

0.0

1.8

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

0.00

0.0

1.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

0.00

0.0

1.0

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.0

1.7

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

0.0

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

0.00

0.0

1.8

—

(40768795) Lymph node Pathology biopsy report

0.00

0.0

1.0

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint L12_PSEUDOPELADE and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have L12_PSEUDOPELADE.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: L12_PSEUDOPELADE – Pseudopelade

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Pseudopelade

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints